Jason Patrick Meyenburg - 03 Jan 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Piekos, attorney-in-fact
Issuer symbol
IRON
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 15:08:07 UTC
Previous filing
18 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Restricted Stock Units Award $0 +123,600 $0.000000 123,600 03 Jan 2022 Common Stock 123,600 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
F2 These Restricted Stock Units shall vest in accordance with certain performance based metrics.